IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $687,465 | -32.5% | 151,091 | +4.5% | 0.00% | – |
Q2 2023 | $1,018,252 | +17.2% | 144,638 | +1.7% | 0.00% | – |
Q1 2023 | $868,774 | +40.4% | 142,189 | +46.9% | 0.00% | – |
Q4 2022 | $618,642 | -33.6% | 96,814 | -0.4% | 0.00% | – |
Q3 2022 | $931,000 | -94.9% | 97,178 | -94.1% | 0.00% | -100.0% |
Q2 2022 | $18,087,000 | -34.6% | 1,638,255 | -1.4% | 0.01% | -28.6% |
Q1 2022 | $27,661,000 | -8.7% | 1,661,292 | +4.7% | 0.01% | 0.0% |
Q4 2021 | $30,297,000 | +19.7% | 1,587,067 | +54.6% | 0.01% | +16.7% |
Q3 2021 | $25,317,000 | -5.9% | 1,026,657 | -0.7% | 0.01% | -14.3% |
Q2 2021 | $26,915,000 | -27.2% | 1,034,365 | -11.4% | 0.01% | -30.0% |
Q1 2021 | $36,975,000 | -50.4% | 1,167,872 | -27.2% | 0.01% | -54.5% |
Q4 2020 | $74,484,000 | +43.4% | 1,605,263 | +1.7% | 0.02% | +22.2% |
Q3 2020 | $51,942,000 | +54.5% | 1,577,816 | +28.8% | 0.02% | +50.0% |
Q2 2020 | $33,622,000 | +511.1% | 1,224,821 | +566.3% | 0.01% | +500.0% |
Q1 2020 | $5,502,000 | +71.5% | 183,826 | +58.6% | 0.00% | +100.0% |
Q4 2019 | $3,209,000 | -2.0% | 115,931 | -13.2% | 0.00% | 0.0% |
Q2 2019 | $3,276,000 | -18.8% | 133,591 | -57.6% | 0.00% | 0.0% |
Q2 2018 | $4,036,000 | – | 315,330 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |